Class I histone deacetylase (HDAC) was demonstrated to promote cardiac hypertrophy, and inhibitors of class I HDACs are potential drugs for the treatment of cardiac hypertrophy [6, 12]. Here, HDAC9 is linked to cardiac hypertrophy.